Literature DB >> 15822128

Cytologic findings and protein expression profiles associated with ductal carcinoma of the breast in ductal lavage specimens using surface-enhanced laser desorption and ionization-time of flight mass spectrometry.

Savvas Mendrinos1, John David L Nolen, Toncred Styblo, Grant Carlson, Jan Pohl, Melinda Lewis, James Ritchie.   

Abstract

BACKGROUND: Early detection of breast carcinoma enhances the chances for patient survival. The authors' work focused on an innovative technique that couples breast ductal lavage (DL) with surface-enhanced laser desorption and ionization-time of flight mass spectrometry (SELDI-TOF MS) to yield a highly sensitive and specific method of breast carcinoma detection.
METHODS: The study group included 16 women who had unilateral, biopsy-proven breast carcinoma. Studying paired DL specimens from each woman (the breast with and the breast without carcinoma), a cytologic investigation was performed on the cells present in the DL samples, and the protein content of the DL fluid was analyzed with the SELDI-TOF MS technique using the strong anionic exchange chip surface.
RESULTS: Only 5 of 16 DL specimens (31%) from breasts with biopsy-proven carcinoma contained malignant cells, whereas the remaining samples contained only histiocytes and clusters of benign ductal epithelium. In contrast, 12 of 16 DL specimens (75%) from breasts that contained carcinoma had a different protein peak pattern compared with the paired DL specimen from the same patient's contralateral, uninvolved breast. This finding was independent of the presence of neoplastic cells in the lavage fluid. In addition, specific protein peaks, which may represent potential biomarkers, were identified in the DL fluids from breasts with carcinoma. Some of these peaks were conserved between different patients.
CONCLUSIONS: The combination of breast DL with SELDI-TOF MS offers a unique and powerful technique for the detection and monitoring of breast carcinoma. This method has the potential to enhance the diagnostic utility of conventional DL cytology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15822128     DOI: 10.1002/cncr.21052

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

Review 1.  Molecular screening for breast cancer prevention, early detection, and treatment planning: combining biomarkers from DNA, RNA, and protein.

Authors:  Katherine Stemke-Hale; Bryan Hennessy; Gordon B Mills; Rahul Mitra
Journal:  Curr Oncol Rep       Date:  2006-11       Impact factor: 5.075

Review 2.  Breast tumor metastasis: analysis via proteomic profiling.

Authors:  Steve Goodison; Virginia Urquidi
Journal:  Expert Rev Proteomics       Date:  2008-06       Impact factor: 3.940

3.  Development of a method based on surface enhanced laser desorption and ionization time of flight mass spectrometry for rapid identification of Klebsiella pneumoniae.

Authors:  Daiwen Xiao; Yongchang Yang; Hua Liu; Hua Yu; Yingjun Yan; Wenfang Huang; Wei Jiang; Weijin Liao; Qi Hu; Bo Huang
Journal:  J Microbiol       Date:  2009-10-24       Impact factor: 3.422

Review 4.  The intraductal approach to the breast: raison d'être.

Authors:  Bonnie L King; Susan M Love
Journal:  Breast Cancer Res       Date:  2006-04-21       Impact factor: 6.466

5.  Proteomics and mass spectrometry for cancer biomarker discovery.

Authors:  Ming Lu; Kym F Faull; Julian P Whitelegge; Jianbo He; Dejun Shen; Romaine E Saxton; Helena R Chang
Journal:  Biomark Insights       Date:  2007-10-03

6.  Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.

Authors:  Kristyna Brozkova; Eva Budinska; Pavel Bouchal; Lenka Hernychova; Dana Knoflickova; Dalibor Valik; Rostislav Vyzula; Borivoj Vojtesek; Rudolf Nenutil
Journal:  Breast Cancer Res       Date:  2008-05-29       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.